Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

Total and biologically active CD154 in patients with SLE.

Juan B de Sanctis¹, Jenny V Garmendia, Ricardo Chaurio

¹Facultad de Medicina, Instituto de Inmunología, University of Central de Venezuela, Caracas, Venezuela.

|October 9, 2009

Summary

Biologically active CD154 tetramer levels are elevated in active systemic lupus erythematosus (SLE) patients. This bioassay effectively distinguishes active SLE from stable disease, aiding in patient assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis.

Frontiers in immunology·2025

Same author

Neglected no more: B cell-mediated anti-tumor immunity.

Seminars in immunology·2022

Same author

Synthesis, Leishmanicidal, Trypanocidal, Antiproliferative Assay and Apoptotic Induction of (2-Phenoxypyridin-3-yl)naphthalene-1(2<i>H</i>)-one Derivatives.

Molecules (Basel, Switzerland)·2022

Same author

One-Step Synthesis of Nanoliposomal Copper Diethyldithiocarbamate and Its Assessment for Cancer Therapy.

Pharmaceutics·2022

Same author

The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises.

International journal of molecular sciences·2022

Same author

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?

International journal of molecular sciences·2021

Area of Science:

Immunology
Rheumatology

Background:

CD154, a tumor necrosis factor receptor family member, influences various biological responses.
Elevated soluble CD154 (sCD154) levels are observed in systemic lupus erythematosus (SLE) patients.
Limited research has focused on the biologically active tetrameric form of sCD154.

Purpose of the Study:

To evaluate the biological activity of serum CD154 tetramer in SLE patients.
To assess the utility of a bioassay for measuring biologically active sCD154 (ba-sCD154) in SLE.
To correlate ba-sCD154 levels with disease activity and treatment status in SLE.

Main Methods:

Measurement of total sCD154 serum concentration.
Bioassays to determine the biological activity of sCD154 (ba-sCD154) by assessing B cell activation and nitrite/peroxide production.

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Related Experiment Videos

Last Updated: Jun 19, 2026

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Comparison of ba-sCD154 levels in non-treated SLE patients, patients with high SLE Disease Activity Index (SLEDAI) scores, stable SLE patients, and normal healthy donors (NHD).

Monitoring of ba-sCD154 levels in patients with high SLEDAI after successful treatment.

Main Results:

Total sCD154 serum concentration was significantly increased in SLE patients compared to NHD (12.5 +/- 8.2 vs. 3.9 +/- 1.2 ng/ml; p < 0.001).
ba-sCD154 was significantly elevated in non-treated SLE patients (7.4 +/- 3.4 ng/ml) and those with high SLEDAI scores (5.3 +/- 2.9 ng/ml).
Stable SLE patients showed ba-sCD154 levels comparable to NHD (1.3 +/- 1.2 ng/ml vs. 0.8 +/- 0.2 ng/ml).
Successful treatment led to a significant decrease in ba-sCD154 levels in patients with SLEDAI > 8.

Conclusions:

The bioassay for ba-sCD154 is a valuable tool for differentiating active from stable SLE.
Elevated ba-sCD154 levels correlate with active disease and lack of treatment in SLE patients.
This assay can aid in monitoring treatment response and disease status in SLE.